Medgenics gets patent for EPO pump; Alexza's Adusave aerosol loxapine coming closer to market;

> Adusave, aerosol-delivered loxapine using Alexza Pharmaceuticals' ($ALXA) Staccato delivery system, could gain approval in the U.S. and Europe next month. Article | Press release

> Medgenics' ($MDGN) Epodure Biopump technology has been granted a U.S. patent for the delivery of erythropoietin (EPO). Article

> Impax Laboratories and Perrigo are working together to develop, manufacture, and commercialize a topical generic drug. Article

> Sanovas has received a patent for its nested balloon catheter for localized drug delivery, part of its Vas Zeppelin Smart Catheter technology portfolio. Article

> Alliqua is looking into using its proprietary transdermal delivery platform in the cosmeceutical industry. Press release

> Italian researchers are developing niosomes to deliver anti-inflammatory drugs. Article

And Finally… Whipworm infection could alleviate autism--a novel drug delivery device? Article

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.